TP53 and lung carcinoma: Because the synergistic effect of CPT/NPOA on the antiproliferation and apoptosis can be observed in both A549 (wild type-p53) and H1299 (null-p53) cells (Figure 1), we suggest that the synergistic anti-lung-cancer induced by CPT/NPOA combination may be p53-independent.